Robert O'Connor

Title: The Innovations of Robert O'Connor

Introduction

Robert O'Connor is an accomplished inventor based in Pipersville, PA (US). He has made significant contributions to the pharmaceutical industry, particularly in the development of high-dose finished pharmaceutical dosage forms. His innovative work focuses on improving the efficacy and safety of pharmaceutical products.

Latest Patents

O'Connor holds a patent for a finished pharmaceutical dosage form of a methenamine salt, specifically methenamine mandelate. This invention contemplates a high-dose finished pharmaceutical dosage form that includes a methenamine salt as an active pharmaceutical ingredient. The key feature of this invention is that the methenamine salt has a moisture content that is less than the upper limit specified in the USP. A preferred embodiment of this invention has a moisture content that is half of the limit set forth in the USP for each particular methenamine salt. An even more preferred embodiment has a moisture content of less than or equal to one-tenth of a percent (0.1%), regardless of the methenamine salt. The invention may also include one or more pharmaceutically acceptable ingredients, ensuring that the moisture content of the high-dose finished pharmaceutical dosage form is less than one percent.

Career Highlights

Robert O'Connor is currently associated with Edenbridge Pharmaceuticals, LLC, where he continues to innovate and contribute to the field of pharmaceuticals. His work is characterized by a commitment to enhancing the quality and effectiveness of pharmaceutical formulations.

Conclusion

Robert O'Connor's contributions to the pharmaceutical industry through his innovative patent demonstrate his dedication to improving healthcare solutions. His work on methenamine salts exemplifies the importance of innovation in developing effective pharmaceutical products.